Klaus Schafer, Director at Altimmune, Inc. (ALT), bought 2,000 shares at $11.99 ($24K) on 2020-12-10, disclosed to the SEC on 2020-12-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.